Recursion Pharmaceuticals, Inc. (RXRX)
4.63
-0.15
(-3.14%)
USD |
NASDAQ |
Oct 06, 16:00
4.48
-0.15
(-3.24%)
After-Hours: 07:39
Recursion Pharmaceuticals Total Assets (Quarterly) : 1.213B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.213B |
| March 31, 2026 | 1.340B |
| December 31, 2025 | 1.528B |
| September 30, 2025 | 1.400B |
| June 30, 2025 | 1.302B |
| March 31, 2025 | 1.305B |
| December 31, 2024 | 1.449B |
| September 30, 2024 | 726.50M |
| June 30, 2024 | 775.86M |
| March 31, 2024 | 557.85M |
| December 31, 2023 | 653.70M |
| September 30, 2023 | 630.82M |
| Date | Value |
|---|---|
| June 30, 2023 | 666.70M |
| March 31, 2023 | 627.37M |
| December 31, 2022 | 701.29M |
| September 30, 2022 | 611.53M |
| June 30, 2022 | 672.52M |
| March 31, 2022 | 734.32M |
| December 31, 2021 | 610.34M |
| September 30, 2021 | 658.61M |
| June 30, 2021 | 698.59M |
| March 31, 2021 | 271.94M |
| December 31, 2020 | 298.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Editas Medicine, Inc. | 237.36M |
| Amgen, Inc. | 95.64B |
| Halozyme Therapeutics, Inc. | 2.577B |
| Novavax, Inc. | 955.58M |
| AVITA Medical, Inc. | 47.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 297.66M |
| Shareholders Equity (Quarterly) | 915.00M |
| Debt to Equity Ratio | 0.0728 |
| Current Ratio | 5.034 |
| Net Debt Paydown Yield | 0.27% |